Establishment of a cell-based filovirus entry inhibitor evaluation system.
- Author:
Qing CHEN
;
Ying GUO
- Publication Type:Journal Article
- MeSH:
Antiviral Agents;
pharmacology;
Drug Evaluation, Preclinical;
methods;
Ebolavirus;
drug effects;
physiology;
Genes, Reporter;
Glycoproteins;
genetics;
Hemorrhagic Fever, Ebola;
Humans;
Luciferases;
Viral Proteins;
genetics;
Virus Internalization;
drug effects
- From:
Acta Pharmaceutica Sinica
2015;50(12):1538-1544
- CountryChina
- Language:Chinese
-
Abstract:
Ebola virus, the cause of severe and fatal hemorrahagic fever in humans, belongs to filovirus family. This study was designed to establish a cell-based screening and evaluation system in the pharmacological study of antivirus compounds. Three reporter systems were established with recombinant pseudoviral luciferase of HIV core (pNL4-3.Luc.R(-)E(-)) packed with filovirus glycoprotein (EBOV-Zaire GP/HIV-luc, EBOV-Sudan GP/HIV-luc and Marburg GP/HIV-luc), which are required for virus entry of cells. The level of filovirus entry was determined by the expression of luciferase reporter gene in the infected cells. For screening of filovirus entry inhibitors, the vesicular stomatitis G packed pseudovirions (VSVG/HIV-luc) was used to determine the compound specificity. The results of known filovirus entry inhibitors demonstrated successful establishment of the new model systems, which would be useful in high throughput screening of anti-filovirus drugs in the future.
